Inergetics Inc (NRTI) Return on Equity ROE from the second quarter 2015 to second quarter 2014 and annually, average high and low, overall ranking from Jun 30 2015 to Jun 30 2014 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Inergetics Inc  (NRTI)

Inergetics Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Inergetics Inc in the second quarter 2015?
Due to the lack of equity, it was not possible to calculate Inergetics Inc's return on equity (ROE) in its second quarter 2015

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2015)
II. Quarter		 (Mar 31 2015)
I. Quarter		 (Dec 31 2014)
IV. Quarter		 (Sep 30 2014)
III. Quarter		 (Jun 30 2014)
II. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - 104.81 % - -
Net Income (TTM) in Millions -6 -8 -8 -9 -7
Return On Equity (TTM) - - - - -
NRTI's Total Ranking # # # # #
Equity (TTM) in Millions -21 -22 -19 -23 -19
Seq. Equity Change - - - - -
Seq. Net Income Change - - - - -

Back to NRTI Management Effectiveness >> NRTI's 5 Years Annual ROE >> Compare NRTI ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





NRTI Annual Return On Equity (Dec 31 2014)
2014		 (Dec 31 2013)
2013		 (Dec 31 2012)
2012		 (Dec 31 2011)
2011
Total Equity in Millions -19 -16 -5 -5 0
Y / Y Equity Change - - - - -
Net Income in Millions -8 -4 -4 -5 0
Y / Y Net Income Change - - - - -
Return On Equity - - - - -

Back to NRTI Management Effectiveness >> NRTI's 5 Years Annual ROE >> Compare NRTI ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
NRTI's' Return on Equity at Yahoo Finance
NRTI's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for NRTI's Competitors
Subscribers only: Roe for Inergetics Inc's Suppliers
Subscribers only: Return On Equity for NRTI's Customers




Companies with similar Return On Equity at Jun 30 2015, within Healthcare Sector ROE
Ligand Pharmaceuticals Incorporated  73.32 %
Lumos Pharma Inc   64.61 %
Abbvie Inc   62.83 %
Journey Medical Corp  54.68 %
Supernus Pharmaceuticals inc   52.60 %
Abiomed Inc   51.19 %
Mettler toledo International Inc   48.01 %
Vanda Pharmaceuticals Inc   45.41 %
Teligent Inc   44.26 %
Diversicare Healthcare Services Inc   42.10 %
China Biologic Products Holdings Inc   41.47 %
Pacific Health Care Organization Inc  40.34 %
Catalent Inc   40.10 %
Brainstorm Cell Therapeutics inc   38.60 %
Lannett Company Inc  37.42 %
Amag Pharmaceuticals inc   37.36 %
Encompass Health Corporation  36.91 %
Enanta Pharmaceuticals Inc  36.35 %
3m Company  35.33 %
Celgene Corp  34.63 %
Zoetis Inc   32.26 %
Vaso Corporation  32.14 %
Illumina Inc   31.57 %
Biogen Inc   30.72 %
Ani Pharmaceuticals Inc  28.50 %
Misonix Inc   28.41 %
Iridex Corp  27.96 %
Elite Health Systems Inc   27.74 %
Nevro Corp   27.65 %
Baxter International Inc   27.49 %

Date modified: 2026-09-08T15:21:58+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.